Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rory Wolfe

Showing results (381-390 of 424) with videos related to

Pageof 43
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2023
Validation of newly derived polygenic risk scores for dementia in a prospective study of older individualsChenglong Yu, Joanne Ryan, Suzanne G Orchard, et al.
JAMA Internal Medicine|November 7, 2022
Daily Low-Dose Aspirin and Risk of Serious Falls and Fractures in Healthy Older People: A Substudy of the ASPREE Randomized Clinical TrialAnna L Barker, Renata Morello, Le Thi Phuong Thao, et al.
Kidney International Reports|January 19, 2026
Clonal Hematopoiesis and Kidney Function in the ASPREE CohortJasmine Singh, Kevan R Polkinghorne, Rory Wolfe, et al.
JAMA Network Open|July 26, 2023
Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical TrialGeoffrey C Cloud, Jeff D Williamson, Le Thi Phuong Thao, et al.
Age and Ageing|April 25, 2023
Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trialZhen Zhou, Andrea J Curtis, Alice Owen, et al.
European Journal of Preventive Cardiology|June 6, 2025
Stratification by CVD risk equations does not inform the use of aspirin for primary prevention in older adultsEnayet K Chowdhury, Michael E Ernst, Mark R Nelson, et al.
Contemporary Clinical Trials|November 4, 2017
The Study of Neurocognitive Outcomes, Radiological and Retinal Effects of Aspirin in Sleep Apnoea- rationale and methodology of the SNORE-ASA studyStephanie Alison Ward, Elsdon Storey, Robyn L Woods, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 3, 2022
Combination of gait speed and grip strength to predict cognitive decline and dementiaSuzanne G Orchard, Galina Polekhina, Joanne Ryan, et al.
The Lancet. Healthy Longevity|February 28, 2022
A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial dataJohannes T Neumann, Le T P Thao, Emily Callander, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2008
SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumoniaPatrick G P Charles, Rory Wolfe, Michael Whitby, et al.
Pageof 43

Showing results (381-390 of 424) with videos related to

Sort By:
Pageof 43
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2023
Validation of newly derived polygenic risk scores for dementia in a prospective study of older individualsChenglong Yu, Joanne Ryan, Suzanne G Orchard, et al.
JAMA Internal Medicine|November 7, 2022
Daily Low-Dose Aspirin and Risk of Serious Falls and Fractures in Healthy Older People: A Substudy of the ASPREE Randomized Clinical TrialAnna L Barker, Renata Morello, Le Thi Phuong Thao, et al.
Kidney International Reports|January 19, 2026
Clonal Hematopoiesis and Kidney Function in the ASPREE CohortJasmine Singh, Kevan R Polkinghorne, Rory Wolfe, et al.
JAMA Network Open|July 26, 2023
Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical TrialGeoffrey C Cloud, Jeff D Williamson, Le Thi Phuong Thao, et al.
Age and Ageing|April 25, 2023
Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trialZhen Zhou, Andrea J Curtis, Alice Owen, et al.
European Journal of Preventive Cardiology|June 6, 2025
Stratification by CVD risk equations does not inform the use of aspirin for primary prevention in older adultsEnayet K Chowdhury, Michael E Ernst, Mark R Nelson, et al.
Contemporary Clinical Trials|November 4, 2017
The Study of Neurocognitive Outcomes, Radiological and Retinal Effects of Aspirin in Sleep Apnoea- rationale and methodology of the SNORE-ASA studyStephanie Alison Ward, Elsdon Storey, Robyn L Woods, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 3, 2022
Combination of gait speed and grip strength to predict cognitive decline and dementiaSuzanne G Orchard, Galina Polekhina, Joanne Ryan, et al.
The Lancet. Healthy Longevity|February 28, 2022
A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial dataJohannes T Neumann, Le T P Thao, Emily Callander, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2008
SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumoniaPatrick G P Charles, Rory Wolfe, Michael Whitby, et al.
Pageof 43